Latest Coronavirus Disease COVID 19 News and Research
Portable analyzer rapidly detects anti-virus antibody in blood serum
Researchers have succeeded in detecting anti-avian influenza virus antibody in blood serum within 20 minutes, using a portable analyzer they have developed to conduct rapid on-site bio tests. If a suitable reagent is developed, this technology could be used to detect antibodies against SARS-CoV-2, the causative virus of COVID-19.
Different immune responses can occur in Covid-19, shows study
The human immune system is reactive to more than just the viral protein on which researchers have focused to date. This is relevant for tests and potential vaccines.
IberoGEN develops kit to detect coronavirus on surfaces susceptible to contamination
Company IberoGEN at the Miguel Hernández University of Elche (UMH) has developed a test for the early detection of coronavirus on surfaces susceptible to contamination from everyday use, such as handles, railings, switches, telephones, and keyboards, which is intended for comprehensive service companies as well as specialised entities.
UAE develops laser-based technology for faster, mass-scale coronavirus screening
QuantLase Imaging Lab, the medical-research arm of the Abu Dhabi Stock Exchange-listed International Holdings Company (IHC), announced that it has developed novel equipment which enables for much faster mass screenings, with test results available in seconds and allowing testing on a wider scale.
Blood test could reveal how the immune system responds to coronavirus
A highly detailed analysis of the composition of immune cells in the blood of patients with COVID-19, reveals new aspects of how the SARS-Cov-2 coronavirus causes disease.
UK has the largest gender health gap in G20, study reveals
According to WHO, men are living healthier and longer lives than ever before but are still more likely to be burdened by illness and are outlived by women in every country.
New review analyzes evidence and strategies to manage the SARS-CoV-2 virus
How should orthopaedic surgeons respond to the COVID-19 pandemic? A review in The Journal of Bone & Joint Surgery analyzes evidence and strategies for managing the novel SARS-CoV-2 virus - including critical lessons from past pandemics.
Americans' confidence in medical scientists has grown since the coronavirus outbreak
Americans' confidence in medical scientists has grown since the coronavirus outbreak first began to upend life in the United States, as have perceptions that medical doctors hold very high ethical standards, according to a new Pew Research Center report.
Changes in antibodies and RNA shedding during early SARS-CoV-2 infection
As the COVID-19 pandemic and its far-reaching implications continue to unfold globally and disrupt our normal way of life, scientists and researchers are racing to find an appropriate vaccine or therapeutic drug. This process involves understanding how the virus interacts with the host cell, the dynamics of the host immune response, and the eventual outcome.
Despite low stroke rates among COVID-19 patients, cases are still more severe
The rate of strokes in COVID-19 patients appears relatively low, but a higher proportion of those strokes are presenting in younger people and are often more severe compared to strokes in people who do not have the novel coronavirus.
Online survey launched to understand link between coronavirus restrictions and osteoarthritis risk
Researchers at Loughborough University are investigating how changes in physical activity that are a result of the global health pandemic are related to osteoarthritis development and symptoms.
New review discusses findings on coronavirus immunity
A new review discusses the findings from over 40 studies on coronavirus immunity and what they could mean for the Covid-19 pandemic.
Study to examine how stem cell transplant patients react to COVID-19 infection
A new study will look at how patients, who receive stem cell transplants for blood cancers and blood disorders, react to COVID-19 infection during their recovery.
ss_cdc5ce81fb474413a24d492583320f8b-150x125.jpg "Panasonic team develops prototype breathing devices to help hospitalized COVID-19 patients")
Panasonic team develops prototype breathing devices to help hospitalized COVID-19 patients
The team at Panasonic Manufacturing UK’s facility in Cardiff have produced 80 prototype breathing devices to assist hospital patients suffering from COVID-19.
IL-6 blocker use in severe COVID-19 increases risk of secondary infections
With many hundreds of thousands of deaths due to the current COVID-19 pandemic, there is a rush to find an effective vaccine or drug against the virus. A new study on the preprint server medRxiv* in May 2020 shows that the use of some biologically plausible drugs may be counterproductive, and care should be taken when trying out unproven therapies.
Scientists are harnessing artificial intelligence and satellite data to predict blazes across Western US
As California and the American West head into fire season amid the coronavirus pandemic, scientists are harnessing artificial intelligence and new satellite data to help predict blazes across the region.
Indica Labs and Octo announce launch of online COVID Digital Pathology Repository
Indica Labs, a leading provider of computational pathology software, and Octo, a premiere information technology systems provider to the U.S. Federal Government, are pleased to announce the online COVID Digital Pathology Repository, a virtual collection of high resolution microscopic COVID-related human tissue images hosted at the National Institutes of Health.
Study evaluates the effectiveness of interferon beta 1b in COVID-19 pneumonia
As the world struggles to overcome the current COVID-19 pandemic with non-pharmacological interventions, in the absence of an effective drug or vaccine, existing immunomodulators are being repurposed. A new study published on the preprint server medRxiv* in May 2020 shows no clinical benefit to the use of one such drug, called interferon beta 1b (IFN beta1b).
Preparing to meet SARS-CoV-2 head-on with a panel of neutralizing antibodies
A new study published on the preprint server bioRxiv in May 2020 describes a panel of neutralizing antibodies that bind to multiple attachment sites on the spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the current COVID-19 disease pandemic.
Prediction of incubation period for COVID-19 and other viruses
A new study published on the preprint server bioRxiv* in May 2020 provides a method to estimate the incubation period for any new pathogen, which could help to define the optimal quarantine period necessary to keep the spread of the causative agent in check.
No hay comentarios:
Publicar un comentario